|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/13 | |
| A61K 45/06 | |||
| A61P 27/02 |
| (11) | Number of the document | 3103468 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16164865.4 |
| Date of filing the European patent application | 2006-10-12 | |
| (97) | Date of publication of the European application | 2016-12-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-15 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 596709 | 2005-10-14 | US | |
| 597431 P | 2005-11-30 | US | |
| 805509 P | 2006-06-22 | US | |
| 548631 | 2006-10-11 | US |
| (72) |
Schiffman, Rhett M., US
Barnett, Pamela S., US
Feinermann, Gregg, US
Barth, Neil, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | PREVENTION OF DRUG-ASSOCIATED KERATOCONJUNCTIVITIS WITH A CYCLOSPORIN |
| PREVENTION OF DRUG-ASSOCIATED KERATOCONJUNCTIVITIS WITH A CYCLOSPORIN |